Ozanezumab
Ozanezumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting RTN4/NOGO, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.
Ozanezumab has been used in trials studying the treatment of Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis, Relapsing-Remitting.
Ozanezumab has been used in trials studying the treatment of Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis, Relapsing-Remitting.
| Supplier | Abbexa Ltd. |
|---|---|
| Product # | abx831271-1MG |
| Pricing | 1 mg USD $1334.0 |
| Clonality | Monoclonal |
| Conjugation | Unconjugated |
| Host | Human |
| Tested Applications | ELISA, WB |
| CAS Number | 1310680-64-8 |
| Availability | Shipped within 7-12 working days. |
| Dry Ice | No |
| Note |
|